A new drug has been approved by the Food and Drug Administration to treat advanced pancreatic cancer. This breakthrough could potentially extend the survival of patients with metastatic pancreatic cancer.

The FDA's approval was announced on Wednesday, marking a significant development for those affected by this condition.

Further information about the drug and its potential impact is available from the source, providing more details about this recent approval and its implications for patients with advanced pancreatic cancer.